Latest Developments in the Biosimilar Market The global pharmaceutical industry is witnessing rapid growth in the biosimilars market as patents for several blockbuster biologic drugs begin to ex...
Key Highlights: Implications: Anyra smashes Eylea pricing barriers, flooding retina clinics with budget-friendly therapy that keeps patients compliant for years. Zydus seizes op...
Emerging Technology Trends in Biopharma The intersection of technology and biopharma isn’t a futuristic idea anymore it’s happening right now. Artificial intelligence (...
Key Highlights: Implications: This partnership accelerates peptide therapy access in high-growth markets, challenging incumbents like Sun Pharma in India’s $500M+ peptide segment whi...
Clinical Trials in India: Growth, Ethics & Global Positioning Recent Industry Context Clinical trials have always been a crucial pillar of healthcare innovation, acting as the bridge b...
Key Highlights: Implications: Jubilant catapults into top-tier CRO/CDMO contender, snatching complex molecule work from Lonza/Capricor as India chemistry talent goes global. Noid...
Key Highlights: Implications: Lantern’s Bengaluru expansion accelerates U.S. biotech offshoring of AI-drug discovery to India, intensifying talent competition with Dr. Reddy’s and Biocon w...
Latest Developments in Pharma Talent and Innovation India’s pharmaceutical industry has long been recognized for its manufacturing capabilities, particularly in the generics sector. However, in ...
Latest Developments in Peptide-Based Medicines Peptide-based drugs are gaining significant attention in the global pharmaceutical industry due to their ability to target specific biological path...
